Beijing QuantoBio technology Co., LTD

Beijing QuantoBio Biotechnology Co., Ltd. (hereinafter referred to as QuantoBio) is a high-tech enterprise with R&D and production of biological reagents for clinical diagnosis and scientific research as its main business. The company provides flow cytometry total solution for clinical, research and industrial customers. QuantoBio’s flow cytometry technology solution including reagents and instruments, including flow cytometers, monoclonal antibody and multiplex cytokine reagents, etc. It covers clinical-related applications, including immune monitoring of AlDS patients, immune-phenotyping of acute and chronic leukemia and lymphoma, perioper ativeimmune management of blood/organ transplantation and immune status assessment of various clinical patients and risk assessment of primary and secondary infections, etc. Also, QuantoBio can provides related products for research or industrial application, including cell analysis or QC during basic research and translational applications, such as cell biology, cancer cell, immunology, CAR-T, CAR-NK, stem cell related cell and gene therapy, etc. QuantoBio has actively integrated the global marketing resources, attracted top talents and established a distinguished marketing force with international vision. At present, we have built a diagnostic technology platform service team of more than 300 people integrating R&D, manufacturing and sales of reagents and instruments, serving global clinical hospitals, universities, institutions and companies.